EDGAR Filing Documents for 0001144204-14-049285

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001144204-14-049285

Filing Date

2014-08-13

Accepted

2014-08-13 15:01:13

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM F-3	v386590_f3.htm	F-3	403137
2	EXHIBIT 5.1	v386590_ex5-1.htm	EX-5.1	62487
3	EXHIBIT 23.2	v386590_ex23-2.htm	EX-23.2	2919
4	GRAPHIC	tlogo.jpg	GRAPHIC	14213
	Complete submission text file	0001144204-14-049285.txt		489328

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-3 | Act: 33 | File No.: 333-198107 | Film No.: 141037178
SIC: 2834 Pharmaceutical Preparations